GILD and ABBV Related Headlines
Go Back- U.S. biopharma earnings: Eli Lilly (LLY), Pfizer (PFE) take the stage
- Bernstein on US Pharma and Biotech: Who might buy whom?
- Barclays launches U.S. biopharma coverage with four preferred picks
- Trump to announce prescription drug price agreements
- Bernstein on AmericasMedicines.com: 'The Noise Starts, But Not (Yet) from Trump'
- Buy this U.S. large-cap biopharma stock: JPMorgan
